2023/02/20

Forming of a Joint Venture with Accenture Co., Ltd. Accompanied by a Share Transfer of Shionogi Business Partner Co., Ltd.

OSAKA, Japan, February 20, 2023 - Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announced that, at the meeting of its Board of Directors held today, the Directors decided to transfer a portion of the shares of Shionogi Business Partner Co., Ltd., (Head Office: Osaka, Japan; President: Yuji Hosogai; hereafter "Shionogi Business Partner"), a wholly-owned group company, to Accenture Co., Ltd. (Head Office: Tokyo, Japan; Chief Executive Officer: Atsushi Egawa; hereafter " Accenture ") to form a joint venture.

 

In its reorganization in July 2022, to improve business process efficiency, Shionogi merged four group companies running back office functions such as human resources, general affairs, accounting and finance into Shionogi Business Partner Co., Ltd.

In order to further accelerate business reforms and enhance the expertise of employees, we have decided to transfer 80% of Shionogi Business Partner's stock to Accenture and form a joint venture. The transfer is scheduled to be concluded on July 3, 2023. In addition, prior to the forming of this joint venture, Shionogi Pharmacovigilance Center Co., Ltd. (Head Office: Osaka, Japan; President: Masako Kaneto; hereafter "Shionogi Pharmacovigilance Center") will be absorbed into Shionogi Business Partner on July 1,2023 for the purpose of synergy with Accenture's business process managed services related to safety management operations.

 

By forming a joint venture with Accenture, we will utilize Accenture's strength in indirect business reform know-how to thoroughly improve efficiency. Furthermore, by learning from Accenture's know-how, we will create new opportunities for the professional growth and development of the employees, enabling them to play a greater role in the growth and development of Shionogi Group's business.

 

Together with Shionogi Business Partner and Shionogi Pharmacovigilance Center, Accenture and Shionogi will continue working on the finer details of the establishment ahead of the planned July launch.

 

 

 Outline of the joint venture

Corporate Name

Shionogi Business Partner Company Limited [SBP]

Location

7-6, Doshomachi 4-chome, Chuo-ku, Osaka

Start of operations

July 3, 2023 (planned)

Number of Staff

Approximately 420 (planned)

The main business

ž   Shared services

Contracted services related to the Shionogi Group’s following operations: personnel, administration, public relations, facility management, database management, accounting, finance, procurement, sales support, marketing support, education & training, career development support

ž   Safety management and post-marketing operations of the Shionogi Group as required by the Pharmaceuticals and Medical Devices Act and other regulation

Initial Capitalization

10 million yen

Investment ratio

Accenture 80%, Shionogi 20%

 Company absorbed in the Merger

Shionogi Pharmacovigilance Center Company Limited (as of February 20, 2023)

Corporate Name

Shionogi Pharmacovigilance Center Company Limited [SPV]

Location

7-6, Doshomachi 4-chome, Chuo-ku, Osaka

Representative Person

Masako Kaneto

Date of Establishment

April 3, 2017

Number of Staff

81 (as of January, 2023)

Initial Capitalization

10 million yen

The main business

Safety management and post-marketing operations of the Shionogi Group as required by the Pharmaceuticals and Medical Devices Act and other regulation.

About Accenture

Accenture is a leading global professional services company that helps the world’s leading businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services—creating tangible value at speed and scale.

References

1.     Press release on May 23,2022

Shionogi Announces appointment of Corporate officers, Corporate Reorganization and Personnel Reassignment

 

For Further Information, Contact:

SHIONOGI Website Inquiry Form : https://www.shionogi.com/global/en/contact.html